Product Code: GVR-4-68040-128-3
Respiratory Oxygen Delivery Devices Market Growth & Trends:
The global respiratory oxygen delivery devices market size is expected to reach USD 21.73 billion by 2030, registering a CAGR of 7.9% from 2023 to 2030, according to a new study by Grand View Research, Inc.. The market encompasses diverse medical equipment designed to administer oxygen therapy and aid in respiratory support. These devices are crucial for individuals with various respiratory conditions, ranging from chronic obstructive pulmonary disease (COPD) and asthma to acute situations like COVID-19. The market's growth is primarily driven by factors, such as the increasing prevalence of respiratory disorders, the growing aging global population, technological advancements leading to more efficient & user-friendly devices, rising awareness about respiratory health, and increasing government funding, which highlighted the importance of adequate respiratory care and oxygen therapy.
For instance, in June 2022, The U.S. Agency for International Development (USAID) progressed with its previously announced USD 50 million initiative to enhance worldwide access to medical oxygen. The agency's efforts included commitments to enhance healthcare infrastructure, particularly establishing and upgrading facilities capable of supporting bulk liquid oxygen in 50 locations globally. USAID's estimates indicated that this investment would provide medical oxygen across more than 20,000 beds, potentially saving the lives of hundreds of thousands of patients annually. The investment addresses a crucial aspect of respiratory care, particularly in regions with limited resources and healthcare infrastructure. Improved access to medical oxygen can increase demand for oxygen delivery devices. As healthcare facilities in these regions are reinforced and equipped to provide life-saving oxygen therapy, the product demand is likely to increase, thereby positively impacting the market growth.
Respiratory Oxygen Delivery Devices Market Report Highlights:
- The market growth is attributed to the increasing prevalence of respiratory diseases, such as asthma, COPD, etc., and the rising global geriatric population are major factors driving the market's growth
- The oxygen masks segment accounted for the largest revenue share of 35.96% in 2022
- The hospitals segment dominated the market with a revenue share of 51.76% in 2022 and is expected to continue its dominance with the fastest CAGR of 8.0% from 2023 to 2030
- Asia Pacific dominated the market with a revenue share of 42.40% in 2022 and is expected to continue its dominance over the forecast period
- The market growth in this region can be attributed to the presence of highly populated countries, such as China and India, the availability of the latest technologies, and product launches
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information Or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing global elderly population
- 3.2.1.2. Increasing prevalence of infectious & respiratory diseases
- 3.2.1.3. Supportive initiatives by government and private organizations
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Product recall & failure
- 3.2.2.2. Overstocking of devices due to COVID-19
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
- 4.1. Respiratory Oxygen Delivery Devices Market: Product Movement Analysis
- 4.2. Oxygen Masks
- 4.2.1. Oxygen Masks Market, 2018 - 2030 (USD Million)
- 4.3. Nasal Cannula
- 4.3.1. Nasal Cannulas Market, 2018 - 2030 (USD Million)
- 4.4. Venturi Masks
- 4.4.1. Venturi Masks Market, 2018 - 2030 (USD Million)
- 4.5. Non-rebreather Masks
- 4.5.1. Non-rebreather Masks Market, 2018 - 2030 (USD Million)
- 4.6. Bag Valve Masks
- 4.6.1. Bag Valve Masks Market, 2018 - 2030 (USD Million)
- 4.7. CPAP Masks
- 4.7.1. CPAP Masks Systems Market, 2018 - 2030 (USD Million)
- 4.8. Others
- 4.9. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-use Business Analysis
- 5.1. Respiratory Oxygen Delivery Devices Market: End-use Movement Analysis
- 5.2. Hospitals
- 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
- 5.3. Outpatient Facilities
- 5.3.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)
- 5.4. Home Care
- 5.4.1. Home Care Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
- 6.1. Respiratory Oxygen Delivery Devices Market Share By Region, 2022 & 2030
- 6.2. North America
- 6.2.1. SWOT Analysis
- 6.2.2. North America Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.2.3. U.S.
- 6.2.3.1. Key Country Dynamics
- 6.2.3.2. Target Disease Prevalence
- 6.2.3.3. Competitive Scenario
- 6.2.3.4. Regulatory Framework
- 6.2.3.5. U.S. Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.2.4. Canada
- 6.2.4.1. Key Country Dynamics
- 6.2.4.2. Target Disease Prevalence
- 6.2.4.3. Competitive Scenario
- 6.2.4.4. Regulatory Framework
- 6.2.4.5. Canada Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.2. UK
- 6.3.2.1. Key Country Dynamics
- 6.3.2.2. Target Disease Prevalence
- 6.3.2.3. Competitive Scenario
- 6.3.2.4. Regulatory Framework
- 6.3.2.5. UK Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Key Country Dynamics
- 6.3.3.2. Target Disease Prevalence
- 6.3.3.3. Competitive Scenario
- 6.3.3.4. Regulatory Framework
- 6.3.3.5. Germany Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. Key Country Dynamics
- 6.3.4.2. Target Disease Prevalence
- 6.3.4.3. Competitive Scenario
- 6.3.4.4. Regulatory Framework
- 6.3.4.5. France Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Key Country Dynamics
- 6.3.5.2. Target Disease Prevalence
- 6.3.5.3. Competitive Scenario
- 6.3.5.4. Regulatory Framework
- 6.3.5.5. Italy Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Key Country Dynamics
- 6.3.6.2. Target Disease Prevalence
- 6.3.6.3. Competitive Scenario
- 6.3.6.4. Regulatory Framework
- 6.3.6.5. Spain Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Key Country Dynamics
- 6.3.7.2. Target Disease Prevalence
- 6.3.7.3. Competitive Scenario
- 6.3.7.4. Regulatory Framework
- 6.3.7.5. Denmark Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Key Country Dynamics
- 6.3.8.2. Target Disease Prevalence
- 6.3.8.3. Competitive Scenario
- 6.3.8.4. Regulatory Framework
- 6.3.8.5. Sweden Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Key Country Dynamics
- 6.3.9.2. Target Disease Prevalence
- 6.3.9.3. Competitive Scenario
- 6.3.9.4. Regulatory Framework
- 6.3.9.5. Norway Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.2. Japan
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Target Disease Prevalence
- 6.4.2.3. Competitive Scenario
- 6.4.2.4. Regulatory Framework
- 6.4.2.5. Japan Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.3. China
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Target Disease Prevalence
- 6.4.3.3. Competitive Scenario
- 6.4.3.4. Regulatory Framework
- 6.4.3.5. China Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Target Disease Prevalence
- 6.4.4.3. Competitive Scenario
- 6.4.4.4. Regulatory Framework
- 6.4.4.5. India Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.5. Australia
- 6.4.5.1. Key Country Dynamics
- 6.4.5.2. Target Disease Prevalence
- 6.4.5.3. Competitive Scenario
- 6.4.5.4. Regulatory Framework
- 6.4.5.5. Australia Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.6. Thailand
- 6.4.6.1. Key Country Dynamics
- 6.4.6.2. Target Disease Prevalence
- 6.4.6.3. Competitive Scenario
- 6.4.6.4. Regulatory Framework
- 6.4.6.5. Thailand Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.4.7. South Korea
- 6.4.7.1. Key Country Dynamics
- 6.4.7.2. Target Disease Prevalence
- 6.4.7.3. Competitive Scenario
- 6.4.7.4. Regulatory Framework
- 6.4.7.5. South Korea Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Target Disease Prevalence
- 6.5.2.3. Competitive Scenario
- 6.5.2.4. Regulatory Framework
- 6.5.2.5. Brazil Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.5.3. Mexico
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Target Disease Prevalence
- 6.5.3.3. Competitive Scenario
- 6.5.3.4. Regulatory Framework
- 6.5.3.5. Mexico Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.5.4. Argentina
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Target Disease Prevalence
- 6.5.4.3. Competitive Scenario
- 6.5.4.4. Regulatory Framework
- 6.5.4.5. Argentina Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.6. MEA
- 6.6.1. MEA Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Target Disease Prevalence
- 6.6.2.3. Competitive Scenario
- 6.6.2.4. Regulatory Framework
- 6.6.2.5. South Africa Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Target Disease Prevalence
- 6.6.3.3. Competitive Scenario
- 6.6.3.4. Regulatory Framework
- 6.6.3.5. Saudi Arabia Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.6.4. UAE
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Target Disease Prevalence
- 6.6.4.3. Competitive Scenario
- 6.6.4.4. Regulatory Framework
- 6.6.4.5. UAE Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Target Disease Prevalence
- 6.6.5.3. Competitive Scenario
- 6.6.5.4. Regulatory Framework
- 6.6.5.5. Kuwait Respiratory Oxygen Delivery Devices Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Categorization
- 7.1.1. GE Healthcare
- 7.1.1.1. Overview
- 7.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.1.3. Product Benchmarking
- 7.1.1.4. Strategic Initiatives
- 7.1.2. Koninklijke Philips N.V.
- 7.1.2.1. Overview
- 7.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.2.3. Product Benchmarking
- 7.1.2.4. Strategic Initiatives
- 7.1.3. ICU Medical (Smiths Medical)
- 7.1.3.1. Overview
- 7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.3.3. Product Benchmarking
- 7.1.3.4. Strategic Initiatives
- 7.1.4. Invacare Corporation
- 7.1.4.1. Overview
- 7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.4.3. Product Benchmarking
- 7.1.4.4. Strategic Initiatives
- 7.1.5. Medtronic
- 7.1.5.1. Overview
- 7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.5.3. Product Benchmarking
- 7.1.5.4. Strategic Initiatives
- 7.1.6. Fisher & Paykel Healthcare
- 7.1.6.1. Overview
- 7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.6.3. Product Benchmarking
- 7.1.6.4. Strategic Initiatives
- 7.1.7. ResMed
- 7.1.7.1. Overview
- 7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.7.3. Product Benchmarking
- 7.1.7.4. Strategic Initiatives
- 7.1.8. CAIRE Inc. (NGK SPARK PLUG CO., LTD.)
- 7.1.8.1. Overview
- 7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.8.3. Product Benchmarking
- 7.1.8.4. Strategic Initiatives
- 7.1.9. Ltd Linde
- 7.1.9.1. Overview
- 7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.9.3. Product Benchmarking
- 7.1.9.4. Strategic Initiatives
- 7.1.10. Mindray
- 7.1.10.1. Overview
- 7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.10.3. Product Benchmarking
- 7.1.10.4. Strategic Initiatives
- 7.1.11. Chart Industries
- 7.1.11.1. Overview
- 7.1.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.11.3. Product Benchmarking
- 7.1.11.4. Strategic Initiatives
- 7.1.12. Dragerwerk AG & Co. KGaA
- 7.1.12.1. Overview
- 7.1.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.12.3. Product Benchmarking
- 7.1.12.4. Strategic Initiatives
- 7.1.13. DeVilbiss Healthcare
- 7.1.13.1. Overview
- 7.1.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.1.13.3. Product Benchmarking
- 7.1.13.4. Strategic Initiatives
- 7.2. Participant's Overview
- 7.3. Financial Performance
- 7.4. Product Benchmarking
- 7.5. Company Market Share Analysis, 2022
- 7.6. Strategy Mapping
- 7.6.1. Expansion
- 7.6.2. Acquisition
- 7.6.3. Product/Service Launch
- 7.6.4. Others